Advancements in Heart Failure Management: From Precision Medicine to Therapeutic Innovations
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 25 August 2024 | Viewed by 90
Special Issue Editor
2. Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan
3. Department of Medical Informatics, Graduate School of Medicine, Osaka University, Suita, Osaka 565-0871, Japan
Interests: heart failure; imaging; echocardiography; observational studies; medical informatics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Pharmacological innovations as well as multifactorial approaches are helping to expand the potential of managing the heterogeneous nature of heart failure. Promising gene-editing technologies offer potential routes to correct genetic mutations that cause heart failure. Regenerative medicine approaches, including stem cell therapy and tissue engineering, hold great potential for repairing damaged cardiac tissue and restoring function. Precision medicine approaches that take into account genetics, biomarkers, and comorbidities to tailor heart failure treatment to individual patient profiles are gaining attention. The integration of artificial intelligence and machine learning into heart failure management has also enabled the development of predictive models for early intervention, risk stratification, and personalized treatment recommendations.
Despite the availability of current therapies, it should be recognized that not all patients will have an ideal response and often show persistent progression. The prevalence of heart failure continues to increase, and the limitations of existing therapies make the development of new treatment strategies an urgent necessity.
We welcome submissions of original research as well as systematic reviews on the topic of advancements in heart failure management and treatment. State-of-the-art narrative reviews are also eligible for publication.
Dr. Akito Nakagawa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- developments in diagnostics
- pharmacological innovations
- device-based interventions
- multi-omics approaches
- lifestyle modifications
